The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2571-2578

  Vargiolu, Manuela ^a   Fusco, Daniela ^a   Kurelac, Ivana ^a   Dirnberger, Dietmar ^b   Baumeister, Ralf ^b   Morra, Isabella ^c   Melcarne, Antonio ^d   Rimondini, Roberto ^e   Romeo, Giovanni ^a   Bonora, Elena ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FREIBURG   (Germany)

^c REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^d CTO HOSPITAL   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; PROTEIN RET; SURVIVIN; UBIQUITIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE MUTATION; GENE SEQUENCE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOPHYSIS; IN VIVO CULTURE; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST;

MAMMALIA;

EID: 67650251691     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1980     Document Type: Article

References (30)

1. Trupp M, Raynoschek C, Belluardo N, Ibáñez CF 1998 Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase. Mol Cell Neurosci 11:47-63
2. Tahira T, Ishizaka Y, Itoh F, Sugimura T, Nagao M 1990 Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene 5:97-102
3. Arighi E, Borrello MG, Sariola H 2005 RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev 16:441-467
4. Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, Bredesen DE, Edery P, Mehlen P 2000 The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J 19:4056-4063
5. Cañibano C, Rodriguez NL, Saez C, Tovar S, Garcia-Lavandeira M, Borrello MG, Vidal A, Costantini F, Japon M, Dieguez C, Alvarez CV 2007 The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth. EMBO J 26:2015-2028
6. Dirnberger D, Messerschmid M, Baumeister R 2008 An optimized split-ubiquitin cDNA-library screening system to identify novel interactors of the human Frizzled 1 receptor. Nucleic Acids Res 36:e37
7. Ma Q, Whitlock Jr JP 1996 The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 16:2144-2150
8. Carver LA, Bradfield CA 1997 Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 272:11452-11456
9. Lewis BP, Burge CB, Bartel DP 2005 Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20
10. Ritchie W, Théodule FX, Gautheret D 2008 Mireval: a web tool for simple microRNA prediction in genome sequences. Bioinformatics 24:1394-1396
11. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS 2003 MicroRNA targets in Drosophila. Genome Biol 5:R1
12. Zuker M 2003 Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415
13. Melillo RM, Cirafici AM, De Falco V, Bellantoni M, Chiappetta G, Fusco A, Carlomagno F, Picascia A, Tramontano D, Tallini G, Santoro M 2004 The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Am J Pathol 165:511-521
14. Tsui-Pierchala BA, Ahrens RC, Crowder RJ, Milbrandt J, Johnson Jr EM 2002 The long and short isoforms of Ret function as independent signaling complexes. J Biol Chem 277:34618-34625
15. Coulpier M, Anders J, Ibáñez CF 2002 Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival. J Biol Chem 277:1991-1999
16. Kang BH, Altieri DC 2006 Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J Biol Chem 281:24721-24727
17. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gündogdu S, De Menis E, Mäkinen MJ, Launonen V, Karhu A, Aaltonen LA 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228-1230
18. Eng C 1996 Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N Engl J Med 335:943-951
19. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
20. Mulligan LM, Ponder BA 1995 Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 80:1989-1995
21. Georgitsi M, De Menis E, Cannavo S, Makinen MJ, Tuppurainen K, Pauletto P, Curto L, Weil RJ, Paschke R, Zielinski G, Wasik A, Lubinski J, Vahteristo P, Karhu A, Aaltonen LA 2008 Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. Clin Endocrinol (Oxf) 69:621-627
22. Georgitsi M, Heliövaara E, Paschke R, Kumar AV, Tischkowitz M, Vierimaa O, Salmela P, Sane T, De Menis E, Cannavò S, Gündogdu S, Lucassen A, Izatt L, Aylwin S, Bano G, Hodgson S, Koch CA, Karhu A, Aaltonen LA 2008 Large genomic deletions in AIP in pituitary adenoma predisposition. J Clin Endocrinol Metab 93:4146-4151
23. Yu R, Bonert V, Saporta I, Raffel LJ, Melmed S 2006 Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas. J Clin Endocrinol Metab 91:5126-5129
24. Toledo RA, Lourenço Jr DM, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP, Dahia PL 2007 Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. J Clin Endocrinol Metab 92:1934-1937
25. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira Jr A, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M 2008 The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93:2390-2401
26. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabaté MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wémeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montañana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A 2007 Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891-1896
27. Urbano AG, Suá rez-Peñaranda JM, Diéguez C, Alvarez CV 2000 GDNF and RET-gene expression in anterior pituitary-cell types. Endocrinology 141:1893-1896
28. Japón MA, Urbano AG, Sá ez C, Segura DI, Cerro AL, Diéguez C, Alvarez CV 2002 Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors. J Clin Endocrinol Metab 87:1879-1884
29. Xing M 2007 Gene methylation in thyroid tumorigenesis. Endocrinology 148:948-953
30. Segev DL, Umbricht C, Zeiger MA 2003 Molecular pathogenesis of thyroid cancer. Surg Oncol 12:69-90